{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T20:52:35Z","timestamp":1780087955814,"version":"3.54.0"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:sec>\n            <jats:title>Background.<\/jats:title>\n            <jats:p>Withdrawal of life-sustaining therapy (WLST) performed in the circulatory determination of death (DCD) donors leads to cardiac arrest, challenging the utilization of the myocardium for transplantation. The rapid initiation of normothermic regional perfusion or extracorporeal membrane oxygenation after death helps to optimize organs before implantation. However, additional strategies to mitigate the effects of stress response during WLST, hypoxic\/ischemic injury, and reperfusion injury are required to allow myocardium recovery.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods.<\/jats:title>\n            <jats:p>To this aim, our team routinely used a preconditioning protocol for each DCD donation before and during the WLST and after normothermic regional perfusion\/extracorporeal membrane oxygenation. The protocol includes pharmacological treatments combined to reduce oxidative stress (melatonin, <jats:italic toggle=\"yes\">N<\/jats:italic>-acetylcysteine, and ascorbic acid), improve microcirculation (statins), and mitigate organ\u2019s ischemic injury (steroids) and organ ischemia\/reperfusion injury (remifentanil and sevoflurane when the heart is available for transplantation).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results.<\/jats:title>\n            <jats:p>This report presents the first case of recovery of cardiac function, with the only support of normothermic regional reperfusion, following 20\u2009min of a no-touch period and 41\u2009min of functional warm ischemic time in a DCD donor after the preconditioning protocol.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions.<\/jats:title>\n            <jats:p>Our protocol seems to be effective in abolishing the stress response during WLST and, on the other hand, particularly organ protective (and heart protective), giving a chance to donate organs less impaired from ischemia\/reperfusion injury.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/tp.0000000000004940","type":"journal-article","created":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T04:00:36Z","timestamp":1715832036000},"page":"e106-e109","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Successful Recovery of Cardiac Function Following 20 min of a No-touch Period in a Donation After Circulatory Death: A Case Report"],"prefix":"10.1097","volume":"108","author":[{"given":"Paolo","family":"Zanatta","sequence":"first","affiliation":[{"name":"Department of Anesthesiology and Critical Care, Treviso Regional Hospital AULSS 2 Marca Trevigiana, Treviso, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Linassi","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Critical Care, Treviso Regional Hospital AULSS 2 Marca Trevigiana, Treviso, Italy."},{"name":"Department of Pharmaceutical and Pharmacological Sciences, Universit\u00e0 degli Studi di Padova, Padova, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Gasparetto","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Neuro-Cardio-Vascular Department, Treviso Regional Hospital AULSS 2 Marca Trevigiana, Treviso, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Polesello","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Critical Care, Treviso Regional Hospital AULSS 2 Marca Trevigiana, Treviso, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Bussola","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Critical Care, Treviso Regional Hospital AULSS 2 Marca Trevigiana, Treviso, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ennio","family":"Nascimben","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Critical Care, Treviso Regional Hospital AULSS 2 Marca Trevigiana, Treviso, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Minniti","sequence":"additional","affiliation":[{"name":"Division of Cardiac Surgery, Neuro-Cardio-Vascular Department, Treviso Regional Hospital AULSS 2 Marca Trevigiana Piazzale Ospedale 1, Treviso, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Cernetti","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Neuro-Cardio-Vascular Department, Treviso Regional Hospital AULSS 2 Marca Trevigiana, Treviso, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Angelini","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Critical Care, Treviso Regional Hospital AULSS 2 Marca Trevigiana, Treviso, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Feltrin","sequence":"additional","affiliation":[{"name":"Veneto Region Transplant Center Coordination, Veneto Region, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Romano","sequence":"additional","affiliation":[{"name":"Division of Hepato-Pancreatic and Kidney Transplantation Surgery, Treviso Regional Hospital AULSS 2 Marca Trevigiana, Treviso, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Zanus","sequence":"additional","affiliation":[{"name":"Division of Hepato-Pancreatic and Kidney Transplantation Surgery, Treviso Regional Hospital AULSS 2 Marca Trevigiana, Treviso, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Benazzi","sequence":"additional","affiliation":[{"name":"Department of Hospital Strategic Direction, Treviso Regional Hospital AULSS 2 Marca Trevigiana, Treviso, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gino","family":"Gerosa","sequence":"additional","affiliation":[{"name":"Cardiac Surgery Clinic, Department of Cardiac, Thoracic-Vascular Sciences and Public Health, University of Padova, Padova, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,5,16]]},"reference":[{"key":"R1-20250604","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/j.1432-2277.2011.01257.x","article-title":"Current situation of donation after circulatory death in European countries.","volume":"24","author":"Dom\u00ednguez-Gil","year":"2011","journal-title":"Transpl Int"},{"key":"R2-20250604","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s12630-021-01926-2","article-title":"Heart donation and transplantation after circulatory determination of death: expert guidance from a Canadian consensus building process.","volume":"68","author":"Shemie","year":"2021","journal-title":"Can J Anaesth"},{"key":"R3-20250604","doi-asserted-by":"crossref","first-page":"e231","DOI":"10.1097\/TP.0000000000001815","article-title":"A rodent model of cardiac donation after circulatory death and novel biomarkers of cardiac viability during ex vivo heart perfusion.","volume":"101","author":"Kearns","year":"2017","journal-title":"Transplantation"},{"key":"R4-20250604","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.xjtc.2022.11.014","article-title":"Donation after circulatory death heart transplantation using normothermic regional perfusion: the NYU protocol.","volume":"17","author":"James","year":"2023","journal-title":"JTCVS Tech"},{"key":"R5-20250604","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1161\/CIRCULATIONAHA.115.016291","article-title":"Arrhythmic mitral valve prolapse and sudden cardiac death.","volume":"132","author":"Basso","year":"2015","journal-title":"Circulation"},{"key":"R6-20250604","article-title":"Le cure di fine vita e l\u2019anestesista rianimatore: raccomandazioni siaarti per l\u2019approccio alla persona morente. (End-of-life care and the anesthetist: siaarti recommendations for the approach to the dying person).","author":"Malacarne"},{"key":"R7-20250604","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2174\/0929867324666170608111917","article-title":"Beneficial effects of N-acetylcysteine and N-mercaptopropionylglycine on ischemia reperfusion injury in the heart.","volume":"25","author":"Bartekova","year":"2018","journal-title":"Curr Med Chem"},{"key":"R8-20250604","doi-asserted-by":"crossref","first-page":"4117","DOI":"10.1016\/j.bbagen.2013.04.016","article-title":"The chemistry and biological activities of N-acetylcysteine.","volume":"1830","author":"Samuni","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"R9-20250604","first-page":"1202","article-title":"The multifaceted therapeutic role of N-acetylcysteine (NAC) in disorders characterized by oxidative stress.","volume":"19","author":"Raghu","year":"2021","journal-title":"Curr Neuropharmacol"},{"key":"R10-20250604","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1161\/CIRCULATIONAHA.117.027290","article-title":"Potent thrombolytic effect of N-acetylcysteine on arterial thrombi.","volume":"136","author":"Martinez de Lizarrondo","year":"2017","journal-title":"Circulation"},{"key":"R11-20250604","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.2147\/DDDT.S135173","article-title":"High-dose atorvastatin versus moderate dose on early vascular protection after ST-elevation myocardial infarction.","volume":"11","author":"Gavazzoni","year":"2017","journal-title":"Drug Des Devel Ther"},{"key":"R12-20250604","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.lfs.2019.04.057","article-title":"Melatonin protects circulatory death heart from ischemia\/reperfusion injury via the JAK2\/STAT3 signalling pathway.","volume":"228","author":"Lan","year":"2019","journal-title":"Life Sci"},{"key":"R13-20250604","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.clnu.2022.04.004","article-title":"Ascorbic acid in solid organ transplantation: a literature review.","volume":"41","author":"Gori","year":"2022","journal-title":"Clin Nutr"},{"key":"R14-20250604","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1111\/tri.12823","article-title":"Steroids can reduce warm ischemic reperfusion injury in a porcine donation after circulatory death model with ex vivo lung perfusion evaluation.","volume":"29","author":"Martens","year":"2016","journal-title":"Transpl Int"},{"key":"R15-20250604","doi-asserted-by":"crossref","first-page":"13924","DOI":"10.18632\/aging.103604","article-title":"Remifentanil preconditioning protects against hypoxia-induced senescence and necroptosis in human cardiac myocytes in vitro.","volume":"12","author":"Lewinska","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"R16-20250604","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/bjaed\/mkv074","article-title":"Principles of total intravenous anesthesia: practical aspects of using total intravenous anesthesia.","volume":"16","author":"Al-Rifai","year":"2016","journal-title":"BJA Educ"},{"key":"R17-20250604","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.3390\/jcm11092487","article-title":"General purpose pharmacokinetic-pharmacodynamic models for target-controlled infusion of anaesthetic drugs: a narrative review.","volume":"11","author":"Vandemoortele","year":"2022","journal-title":"J Clin Med"},{"key":"R18-20250604","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1186\/s13287-021-02649-3","article-title":"Sevoflurane preconditioning promotes mesenchymal stem cells to relieve myocardial ischemia\/reperfusion injury via TRPC6-induced angiogenesis.","volume":"12","author":"Yang","year":"2021","journal-title":"Stem Cell Res Ther"},{"key":"R19-20250604","article-title":"Overcoming the boundaries of heart warm ischemia in donation after circulatory death: the Padua case.","author":"Gerosa","journal-title":"ASAIO J"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000004940","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T18:05:26Z","timestamp":1749060326000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000004940"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,16]]},"references-count":19,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000004940","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5,16]]}}}